{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:40:33Z","timestamp":1790775633672,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jaci.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T10:52:25Z","timestamp":1528455145000},"page":"1185-1193.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["A bispecific antibody strategy to target multiple type 2 cytokines in asthma"],"prefix":"10.1016","volume":"142","author":[{"given":"Marie","family":"Godar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Deswarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"de Haard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamida","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Blanchetot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart N.","family":"Lambrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.06.002_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaci.2014.06.036","article-title":"Allergens and the airway epithelium response: gateway to allergic sensitization","volume":"134","author":"Lambrecht","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.06.002_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.3049","article-title":"The immunology of asthma","volume":"16","author":"Lambrecht","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.06.002_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","article-title":"Barrier epithelial cells and the control of type 2 immunity","volume":"43","author":"Hammad","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.06.002_bib4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ni.3829","article-title":"The immunology of the allergy epidemic and the hygiene hypothesis","volume":"18","author":"Lambrecht","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.06.002_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaci.2014.10.012","article-title":"Respiratory allergy caused by house dust mites: what do we really know?","volume":"136","author":"Calder\u00f3n","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.06.002_bib6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","article-title":"Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease","volume":"372","author":"Anderson","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2018.06.002_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma","volume":"326","author":"Robinson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib9","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.4049\/jimmunol.1002568","article-title":"Gene\u00a0expression patterns of Th2 inflammation and intercellular communication in asthmatic airways","volume":"186","author":"Choy","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.06.002_bib10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/nri2870","article-title":"Functions of T cells in asthma: more than just TH2 cells","volume":"10","author":"Lloyd","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2018.06.002_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2\u2013driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib12","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1084\/jem.20101376","article-title":"A novel subset of CD4+ TH2 memory\/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma","volume":"207","author":"Wang","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/19420862.2017.1392425","article-title":"Personalized medicine with biologics for severe type 2 asthma: current status and future prospects","volume":"10","author":"Godar","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2018.06.002_bib14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2737","article-title":"The airway epithelium in asthma","volume":"18","author":"Lambrecht","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.201306-1181OC","article-title":"Foxa3 induces goblet cell metaplasia and inhibits innate antiviral immunity","volume":"189","author":"Chen","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib16","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMra0910061","article-title":"Airway mucus function and dysfunction","volume":"363","author":"Fahy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1476-5381.2011.01219.x","article-title":"Cytokine\/anti-cytokine therapy\u2013novel treatments for asthma?","volume":"163","author":"Hansbro","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2018.06.002_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/19420862.2015.1046648","article-title":"Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform","volume":"7","author":"Klarenbeek","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2018.06.002_bib19","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1172\/JCI72316","article-title":"Four individually druggable MET hotspots mediate HGF-driven tumor progression","volume":"124","author":"Basilico","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.06.002_bib20","doi-asserted-by":"crossref","first-page":"18218","DOI":"10.1074\/jbc.274.26.18218","article-title":"A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies","volume":"274","author":"de Haard","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2018.06.002_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/08820130802608238","article-title":"Functional characterization of N297A, a murine surrogate for low-Fc binding anti-human CD3 antibodies","volume":"38","author":"Chao","year":"2009","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jaci.2018.06.002_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/icb.1995.26","article-title":"The effect of IL-4 on antigen expression: a comparison of fluorescence intensity and antigen density","volume":"73","author":"Macardle","year":"1995","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaci.2018.06.002_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00262-006-0180-4","article-title":"Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies","volume":"56","author":"Roovers","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaci.2018.06.002_bib24","first-page":"1","article-title":"Overview of antibody phage-display technology and its applications","volume":"178","author":"Hoogenboom","year":"2002","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaci.2018.06.002_bib25","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1128\/JB.187.13.4531-4541.2005","article-title":"Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection","volume":"187","author":"De Haard","year":"2005","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jaci.2018.06.002_bib26","doi-asserted-by":"crossref","first-page":"31621","DOI":"10.1038\/srep31621","article-title":"Dual\u00a0anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in\u00a0vitro and in\u00a0vivo efficacy","volume":"6","author":"Godar","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2018.06.002_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/protein\/9.7.617","article-title":"'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization","volume":"9","author":"Ridgway","year":"1996","journal-title":"Protein Eng"},{"key":"10.1016\/j.jaci.2018.06.002_bib28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nbt0798-677","article-title":"An efficient route to human bispecific IgG","volume":"16","author":"Merchant","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2018.06.002_bib29","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jaci.2016.12.970","article-title":"Epicutaneous sensitization to house dust mite allergen requires interferon regulatory factor 4\u2013dependent dermal dendritic cells","volume":"140","author":"Deckers","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.06.002_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaci.2016.09.020","article-title":"House dust mite\u2013driven asthma and allergen-specific T cells depend on B cells when the amount of inhaled allergen is limiting","volume":"140","author":"Dullaers","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.06.002_bib31","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1126\/science.aac6623","article-title":"Farm\u00a0dust and endotoxin protect against allergy through A20 induction in lung epithelial cells","volume":"349","author":"Schuijs","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaci.2018.06.002_bib32","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1084\/jem.20101563","article-title":"Inflammatory dendritic cells\u2014not basophils\u2014are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen","volume":"207","author":"Hammad","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2222.1994.tb00920.x","article-title":"Attenuation of allergic airway inflammation in IL-4 deficient mice","volume":"24","author":"Brusselle","year":"1994","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.06.002_bib34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.immuni.2015.07.015","article-title":"Interleukin-21-producing CD4+ T cells promote type 2 immunity to house dust mites","volume":"43","author":"Coquet","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.06.002_bib35","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1126\/science.282.5397.2258","article-title":"Interleukin-13: central mediator of allergic asthma","volume":"282","author":"Wills-Karp","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jaci.2018.06.002_bib36","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1172\/JCI29176","article-title":"SPDEF regulates goblet cell hyperplasia in the airway epithelium","volume":"117","author":"Park","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.06.002_bib37","first-page":"2914","article-title":"SPDEF\u00a0is\u00a0required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production","volume":"119","author":"Chen","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.06.002_bib38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4161\/mabs.4.2.19000","article-title":"Dual targeting strategies with bispecific antibodies","volume":"4","author":"Kontermann","year":"2012","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2018.06.002_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma\u2014present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2018.06.002_bib40","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib41","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/cea.12762","article-title":"Exacerbation risk in severe asthma is stratified by inflammatory phenotype using\u00a0longitudinal measures of sputum eosinophils","volume":"46","author":"Walsh","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.06.002_bib42","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib43","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib44","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib45","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib46","first-page":"00004","article-title":"Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy","volume":"3","author":"Brusselle","year":"2017","journal-title":"ERJ\u00a0Open Res"},{"key":"10.1016\/j.jaci.2018.06.002_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib48","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib49","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1126\/science.282.5397.2261","article-title":"Requirement for IL-13 independently of IL-4 in experimental asthma","volume":"282","author":"Gr\u00fcnig","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jaci.2018.06.002_bib50","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/eji.200324178","article-title":"Antigen-specific production of interleukin (IL)-13 and IL-5 cooperate to mediate IL-4R\u03b1-independent airway hyperreactivity","volume":"33","author":"Webb","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2018.06.002_bib51","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.20020009","article-title":"Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma","volume":"195","author":"Mattes","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.06.002_bib52","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/cea.12358","article-title":"Re-defining the unique roles for eosinophils in allergic respiratory inflammation","volume":"44","author":"Jacobsen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.06.002_bib53","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/all.12655","article-title":"Differential activation of airway eosinophils induces IL-13-mediated allergic Th2 pulmonary responses in mice","volume":"70","author":"Jacobsen","year":"2015","journal-title":"Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918308443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918308443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:13:17Z","timestamp":1758791597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918308443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0091674918308443"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.06.002","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bispecific antibody strategy to target multiple type 2 cytokines in asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}